{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:30:56Z","timestamp":1763389856663,"version":"3.28.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Heidelberg der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chemotherapy drugs efficiently eradicate rapidly dividing differentiated cells by inducing cell death, but poorly target slowly dividing cells, including cancer stem cells and dormant cancer cells, in the later course of treatment. Prolonged exposure to chemotherapy results in a decrease in the proportion of apoptotic cells in the tumour mass. To investigate and characterize the molecular basis of this phenomenon, microarray-based expression analysis was performed to compare tHcred<jats:sup>2<\/jats:sup>-DEVD-EGFP-caspase 3-sensor transfected C-26 tumour cells that were harvested after engraftment into mice treated with or without 5-FU. Peritoneal metastasis was induced by intraperitoneal injection of C-26 cells, which were subsequently reisolated from omental metastatic tumours after the mice were sacrificed by the end of the 10th day after tumour injection. The purity of reisolated tHcred2-DEVD-EGFP-caspase 3-sensor-expressing C-26 cells was confirmed using FLIM, and total RNA was extracted for gene expression profiling. The validation of relative transcript levels was carried out via real-time semiquantitative RT\u2012PCR assays. Our results demonstrated that chemotherapy induced the differential expression of mediators of cancer cell dormancy and cell survival-related genes and downregulation of both intrinsic and extrinsic apoptotic signalling pathways. Despite the fact that some differentially expressed genes, such as BMP7 and Prss11, have not been thoroughly studied in the context of chemoresistance thus far, they might be potential candidates for future studies on overcoming drug resistance.<\/jats:p>","DOI":"10.1007\/s10585-024-10283-5","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T19:01:36Z","timestamp":1712948496000},"page":"707-715","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer"],"prefix":"10.1007","volume":"41","author":[{"given":"Vugar","family":"Yagublu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayram","family":"Bayramov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Reissfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javahir","family":"Hajibabazade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalala","family":"Abdulrahimli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Keese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"issue":"6","key":"10283_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 68(6):394\u2013424","journal-title":"Cancer J Clin"},{"key":"10283_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/978-3-319-25970-3_26","volume-title":"The Surgical Management of Colon Cancer. The ASCRS textbook of colon and rectal surgery","author":"MG Mutch","year":"2016","unstructured":"Mutch MG (2016) The Surgical Management of Colon Cancer. The ASCRS textbook of colon and rectal surgery. Springer, Berlin, pp 443\u2013470"},{"issue":"10","key":"10283_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/DCR.0000000000000926","volume":"60","author":"JD Vogel","year":"2017","unstructured":"Vogel JD et al (2017) The American society of colon and rectal surgeons clinical practice guidelines for the treatment of colon cancer. Dis Colon Rectum 60(10):999\u20131017","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10283_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3747\/co.23.3330","volume":"23","author":"BM Meyers","year":"2016","unstructured":"Meyers BM et al (2016) Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guideline. Curr Oncol 23(6):418\u2013424","journal-title":"Curr Oncol"},{"issue":"30","key":"10283_CR5","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.3748\/wjg.v22.i30.6876","volume":"22","author":"T Hu","year":"2016","unstructured":"Hu T et al (2016) Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol 22(30):6876\u20136889","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10283_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/1440-1681.12581","volume":"43","author":"ST Pan","year":"2016","unstructured":"Pan ST et al (2016) Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol 43(8):723\u2013737","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10283_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tips.2018.12.004","volume":"40","author":"A Recasens","year":"2019","unstructured":"Recasens A, Munoz L (2019) Targeting cancer cell dormancy. Trends Pharmacol Sci 40(2):128\u2013141","journal-title":"Trends Pharmacol Sci"},{"key":"10283_CR8","first-page":"141","volume":"2","author":"X Wang","year":"2019","unstructured":"Wang X, Zhang H, Chen X (2019) Drug resistance and combating drug resistance in cancer. Cancer Drug Resist 2:141\u2013160","journal-title":"Cancer Drug Resist"},{"key":"10283_CR9","first-page":"37","volume-title":"Bcl-2 antiapoptotic family proteins and chemoresistance in cancer. Advances in cancer research","author":"S Maji","year":"2018","unstructured":"Maji S et al (2018) Bcl-2 antiapoptotic family proteins and chemoresistance in cancer. Advances in cancer research. Elsevier, Amsterdam, pp 37\u201375"},{"issue":"1","key":"10283_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ijc.29990","volume":"139","author":"Z Huang","year":"2016","unstructured":"Huang Z et al (2016) Stress management by autophagy: implications for chemoresistance. Int J Cancer 139(1):23\u201332","journal-title":"Int J Cancer"},{"issue":"3","key":"10283_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/bib\/bbv053","volume":"17","author":"JH Oh","year":"2016","unstructured":"Oh JH, Deasy JO (2016) A literature mining-based approach for identification of cellular pathways associated with chemoresistance in cancer. Brief Bioinform 17(3):468\u2013478","journal-title":"Brief Bioinform"},{"key":"10283_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.acr.2018.12.002","volume-title":"Dormancy and cancer stem cells: an enigma for cancer therapeutic targeting","author":"S Talukdar","year":"2019","unstructured":"Talukdar S et al (2019) Dormancy and cancer stem cells: an enigma for cancer therapeutic targeting. Elsevier, Amsterdam, pp 43\u201384"},{"issue":"3","key":"10283_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2174\/156800909788166600","volume":"9","author":"P Gimenez-Bonafe","year":"2009","unstructured":"Gimenez-Bonafe P, Tortosa A, Perez-Tomas R (2009) Overcoming drug resistance by enhancing apoptosis of tumor cells. Curr Cancer Drug Targets 9(3):320\u2013340","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"10283_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/path.1706","volume":"205","author":"DB Longley","year":"2005","unstructured":"Longley DB, Johnston PG (2005) \u00a0Molecular mechanisms of drug resistance. J Pathol 205(2):275\u2013292","journal-title":"J Pathol"},{"key":"10283_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18010074","volume":"18","author":"K Fujita","year":"2017","unstructured":"Fujita K et al (2017) Cancer therapy due to apoptosis: galectin-9. Int J Mol Sci 18:1","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10283_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ijc.24730","volume":"126","author":"M Keese","year":"2010","unstructured":"Keese M et al (2010) Fluorescence lifetime imaging microscopy of chemotherapy-induced apoptosis resistance in a syngenic mouse tumor model. Int J Cancer 126(1):104\u2013113","journal-title":"Int J Cancer"},{"issue":"4","key":"10283_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.molmed.2015.02.005","volume":"21","author":"F Crea","year":"2015","unstructured":"Crea F et al (2015) The epigenetic\/noncoding origin of tumor dormancy. Trends Mol Med 21(4):206\u2013211","journal-title":"Trends Mol Med"},{"issue":"1","key":"10283_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-S3-S1","volume":"11","author":"W-J Lin","year":"2010","unstructured":"Lin W-J, Hsueh H-M, Chen JJ (2010) Power and sample size estimation in microarray studies. BMC Bioinform 11(1):1\u20139","journal-title":"BMC Bioinform"},{"key":"10283_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-7-106","volume":"7","author":"R Tibshirani","year":"2006","unstructured":"Tibshirani R (2006) A simple method for assessing sample sizes in microarray experiments. BMC Bioinform 7:1\u20136","journal-title":"BMC Bioinform"},{"key":"10283_CR20","first-page":"45","volume-title":"The relationship between dormant cancer cells and their microenvironment","author":"N Linde","year":"2016","unstructured":"Linde N, Fluegen G, Aguirre-Ghiso J (2016) The relationship between dormant cancer cells and their microenvironment. Elsevier, Amsterdam, pp 45\u201371"},{"issue":"5573","key":"10283_CR21","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1071553","volume":"296","author":"H Wajant","year":"2002","unstructured":"Wajant H (2002) The Fas signaling pathway: more than a paradigm. Science 296(5573):1635\u20131636","journal-title":"Science"},{"issue":"22","key":"10283_CR22","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","volume":"14","author":"FC Kischkel","year":"1995","unstructured":"Kischkel FC et al (1995) Cytotoxicity-dependent APO\u20101 (Fas\/CD95)\u2010associated proteins form a death\u2010inducing signaling complex (DISC) with the receptor. EMBO J 14(22):5579\u20135588","journal-title":"EMBO J"},{"issue":"4","key":"10283_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H Li","year":"1998","unstructured":"Li H et al (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94(4):491\u2013501","journal-title":"Cell"},{"issue":"5","key":"10283_CR24","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0002-9440(10)64779-7","volume":"157","author":"JC Reed","year":"2000","unstructured":"Reed JC (2000) Mechanisms of apoptosis. Am J Pathol 157(5):1415\u20131430","journal-title":"Am J Pathol"},{"issue":"20","key":"10283_CR25","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1093\/emboj\/17.20.5974","volume":"17","author":"AH Stegh","year":"1998","unstructured":"Stegh AH et al (1998) DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J 17(20):5974\u20135986","journal-title":"EMBO J"},{"issue":"2","key":"10283_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4161\/auto.2.2.2459","volume":"2","author":"D Gozuacik","year":"2006","unstructured":"Gozuacik D, Kimchi A (2006) DAPk protein family and cancer. Autophagy 2(2):74\u201379","journal-title":"Autophagy"},{"issue":"12","key":"10283_CR27","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/cdd.2010.115","volume":"17","author":"C Liang","year":"2010","unstructured":"Liang C (2010) Negative regulation of autophagy. Cell Death Differ 17(12):1807\u20131815","journal-title":"Cell Death Differ"},{"issue":"25","key":"10283_CR28","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1038\/sj.onc.1202588","volume":"17","author":"N Levy-Strumpf","year":"1998","unstructured":"Levy-Strumpf N, Kimchi A (1998) Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Oncogene 17(25):3331\u20133340","journal-title":"Oncogene"},{"issue":"1","key":"10283_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.biocel.2009.09.013","volume":"42","author":"M Lamkanfi","year":"2010","unstructured":"Lamkanfi M, Kanneganti T-D (2010) Caspase-7: a protease involved in apoptosis and inflammation. Int J Biochem Cell Biol 42(1):21\u201324","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"10283_CR30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/onc.2012.126","volume":"32","author":"H Zheng","year":"2013","unstructured":"Zheng H et al (2013) Fas signaling promotes motility and metastasis through epithelial\u2013mesenchymal transition in gastrointestinal cancer. Oncogene 32(9):1183\u20131192","journal-title":"Oncogene"},{"issue":"21","key":"10283_CR31","doi-asserted-by":"publisher","first-page":"10763","DOI":"10.18632\/oncotarget.2498","volume":"5","author":"H Zheng","year":"2014","unstructured":"Zheng H et al (2014) Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein. Oncotarget 5(21):10763","journal-title":"Oncotarget"},{"issue":"1","key":"10283_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00949-4","volume":"13","author":"J Yuan","year":"2020","unstructured":"Yuan J et al (2020) The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. J Hematol Oncol 13(1):1\u201319","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10283_CR33","first-page":"783","volume":"19","author":"Y Xie","year":"2019","unstructured":"Xie Y et al (2019) PI3K\/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia. Mol Med Rep 19(2):783\u2013791","journal-title":"Mol Med Rep"},{"issue":"10","key":"10283_CR34","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","volume":"23","author":"I Hers","year":"2011","unstructured":"Hers I, Vincent EE, Tavar\u00e9 JM (2011) Akt signalling in health and disease. Cell Signal 23(10):1515\u20131527","journal-title":"Cell Signal"},{"issue":"9","key":"10283_CR35","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1517\/14728222.12.9.1139","volume":"12","author":"LS Steelman","year":"2008","unstructured":"Steelman LS et al (2008) Akt as a therapeutic target in cancer. Expert Opin Ther Targets 12(9):1139\u20131165","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"10283_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-0954-x","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang J et al (2019) Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer 18(1):1\u201328","journal-title":"Mol Cancer"},{"issue":"1","key":"10283_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.advenzreg.2006.01.004","volume":"46","author":"JA McCubrey","year":"2006","unstructured":"McCubrey JA et al (2006) Roles of the RAF\/MEK\/ERK and PI3K\/PTEN\/AKT pathways in malignant transformation and drug resistance. Adv Enzyme Regul 46(1):249\u2013279","journal-title":"Adv Enzyme Regul"},{"issue":"6","key":"10283_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s43018-021-00218-4","volume":"2","author":"P Castel","year":"2021","unstructured":"Castel P et al (2021) The present and future of PI3K inhibitors for cancer therapy. Nat cancer 2(6):587\u2013597","journal-title":"Nat cancer"},{"key":"10283_CR39","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.2147\/OTT.S140854","volume":"10","author":"X-l Gao","year":"2017","unstructured":"Gao X-l et al (2017) Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis. Onco Targets Ther 10:5219","journal-title":"Onco Targets Ther"},{"issue":"6","key":"10283_CR40","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Investig 119(6):1420\u20131428","journal-title":"J Clin Investig"},{"issue":"5","key":"10283_CR41","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41388-019-1047-4","volume":"39","author":"V Veschi","year":"2020","unstructured":"Veschi V et al (2020) Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene 39(5):987\u20131003","journal-title":"Oncogene"},{"issue":"12","key":"10283_CR42","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1158\/1535-7163.MCT-08-0715","volume":"7","author":"J Ma","year":"2008","unstructured":"Ma J, Waxman DJ (2008) Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol Cancer Ther 7(12):3670\u20133684","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"10283_CR43","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya M (2011) Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti-and pro-angiogenic therapies. Genes cancer 2(12):1097\u20131105","journal-title":"Genes cancer"},{"issue":"6","key":"10283_CR44","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1083\/jcb.200302047","volume":"161","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt H et al (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6):1163\u20131177","journal-title":"J Cell Biol"},{"issue":"2","key":"10283_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.bbrc.2006.05.153","volume":"346","author":"R Cong","year":"2006","unstructured":"Cong R et al (2006) Hhex is a direct repressor of endothelial cell-specific molecule 1 (ESM-1). Biochem Biophys Res Commun 346(2):535\u2013545","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10283_CR46","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.cellsig.2012.06.004","volume":"24","author":"YH Kang","year":"2012","unstructured":"Kang YH et al (2012) ESM-1 regulates cell growth and metastatic process through activation of NF-\u03baB in colorectal cancer. Cell Signal 24(10):1940\u20131949","journal-title":"Cell Signal"},{"issue":"8","key":"10283_CR47","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/ncb1750","volume":"10","author":"V Kolev","year":"2008","unstructured":"Kolev V et al (2008) EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol 10(8):902\u2013911","journal-title":"Nat Cell Biol"},{"issue":"14","key":"10283_CR48","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/01.CIR.0000160870.93058.DD","volume":"111","author":"FP Limbourg","year":"2005","unstructured":"Limbourg FP et al (2005) Essential role of endothelial Notch1 in angiogenesis. Circulation 111(14):1826\u20131832","journal-title":"Circulation"},{"issue":"1","key":"10283_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/MCB.23.1.14-25.2003","volume":"23","author":"Z-J Liu","year":"2003","unstructured":"Liu Z-J et al (2003) Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 23(1):14\u201325","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10283_CR50","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3892\/or.2015.4016","volume":"34","author":"E Altobelli","year":"2015","unstructured":"Altobelli E et al (2015) HtrA1: its future potential as a novel biomarker for cancer. Oncol Rep 34(2):555\u2013566","journal-title":"Oncol Rep"},{"issue":"43","key":"10283_CR51","doi-asserted-by":"publisher","first-page":"6684","DOI":"10.1038\/sj.onc.1205911","volume":"21","author":"A Baldi","year":"2002","unstructured":"Baldi A et al (2002) The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells. Oncogene 21(43):6684\u20136688","journal-title":"Oncogene"},{"key":"10283_CR52","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.8.1069","author":"A Baldi","year":"2008","unstructured":"Baldi A et al (2008) The serine protease HtrA1 is a novel prognostic factor for human mesothelioma. Future Med. https:\/\/doi.org\/10.2217\/14622416.9.8.1069","journal-title":"Future Med"},{"issue":"5","key":"10283_CR53","first-page":"508","volume":"9","author":"F Zhu","year":"2010","unstructured":"Zhu F et al (2010) Serine protease HtrA1 expression in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 9(5):508\u2013512","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"4","key":"10283_CR54","doi-asserted-by":"publisher","first-page":"e60359","DOI":"10.1371\/journal.pone.0060359","volume":"8","author":"A Lehner","year":"2013","unstructured":"Lehner A et al (2013) Downregulation of serine protease HTRA1 is associated with poor survival in breast cancer. PLoS One 8(4):e60359","journal-title":"PLoS One"},{"issue":"5","key":"10283_CR55","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1365-2559.2011.03818.x","volume":"58","author":"V Catalano","year":"2011","unstructured":"Catalano V et al (2011) HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer. Histopathology 58(5):669\u2013678","journal-title":"Histopathology"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-024-10283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-024-10283-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-024-10283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T05:15:34Z","timestamp":1729746934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-024-10283-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10283"],"URL":"https:\/\/doi.org\/10.1007\/s10585-024-10283-5","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"type":"print","value":"0262-0898"},{"type":"electronic","value":"1573-7276"}],"subject":[],"published":{"date-parts":[[2024,4,12]]},"assertion":[{"value":"22 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Experiments were performed in accordance with German legislation on the protection of animals and  the Guide for the Care and Use of Laboratory Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}